These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3696351)

  • 21. [Hypertension emergencies].
    Baccar H; Bezdah L; Ouechtati W; Kasri R
    Tunis Med; 2000 Jan; 78(1):14-23. PubMed ID: 10894031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do intensive blood pressure lowering and low-dose ASA help our hypertensive patients?
    Evans MF
    Can Fam Physician; 1998 Dec; 44():2655-7. PubMed ID: 9870118
    [No Abstract]   [Full Text] [Related]  

  • 26. Cerebral blood flow and calcium antagonists in hypertension.
    Conen D; Bertel O; Dubach UC
    J Hypertens Suppl; 1987 Dec; 5(4):S75-80. PubMed ID: 3326921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension control and care at Mulago Hospital ambulatory clinic, Kampala-Uganda.
    Ssinabulya I; Nabunnya Y; Kiggundu B; Musoke C; Mungoma M; Kayima J
    BMC Res Notes; 2016 Nov; 9(1):487. PubMed ID: 27855717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine arterial hypertension: therapeutic approach in clinical practice.
    Mazza A; Armigliato M; Zamboni S; Rempelou P; Rubello D; Pessina AC; Casiglia E
    Minerva Endocrinol; 2008 Dec; 33(4):297-312. PubMed ID: 18923367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
    Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
    Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Control of blood pressure in prevention of hypertensive end-organ damage].
    Kido M; Ando K; Fujita T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():389-93. PubMed ID: 15171405
    [No Abstract]   [Full Text] [Related]  

  • 32. Should we prefer different drugs to treat hypertension in older and younger adults? Practical implications of clinical trials: European perspective.
    Verdecchia P; Gentile G; Angeli F; Reboldi G
    Pol Arch Med Wewn; 2008 Sep; 118(9):513-6. PubMed ID: 18846987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences between blood-pressure-lowering drugs.
    MacMahon S; Neal B
    Lancet; 2000 Jul; 356(9227):352-3. PubMed ID: 10972362
    [No Abstract]   [Full Text] [Related]  

  • 34. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on intervention in arterial hypertension. Recommendations by experts and practical antihypertensive therapy. German Hypertension League].
    Trenkwalder P
    Fortschr Med; 1999 Feb; 117(6):24, 25-8, 30 passim. PubMed ID: 10095298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The challenge of blood pressure management in neurologic emergencies.
    Talbert RL
    Pharmacotherapy; 2006 Aug; 26(8 Pt 2):123S-130S. PubMed ID: 16863478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity hypertension. Converting enzyme inhibitors and calcium antagonists.
    Frohlich ED
    Hypertension; 1992 Jan; 19(1 Suppl):I119-23. PubMed ID: 1730448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials].
    Schillaci G; Vaudo G
    Ital Heart J Suppl; 2001 Jul; 2(7):799-802. PubMed ID: 11508301
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choice of anti-hypertensive agents in diabetic subjects.
    Patel BM; Mehta AA
    Diab Vasc Dis Res; 2013 Sep; 10(5):385-96. PubMed ID: 23811601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.